Expansion Therapeutics
PrivateLast Round
Series B
Sep 29, 2021
Total Funding Raised
$135.3M
Company Overview
Expansion Therapeutics is a biotechnology company that develops small molecule binders as transformative oral medicines aimed at treating severe RNA-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expansion Therapeutics Comparables
Compare Expansion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 94% | |
| Arrakis Therapeutics | 94% | |
| Skyhawk Therapeutics | 89% | |
Expansion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 29, 2021 | ||||
| Series A | Jan 3, 2018 | ||||
| Seed | May 31, 2017 |
Expansion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| RA Capital Management | Series A, Series B |
| Westlake Village BioPartners | Series B |
| Acks | Series A |
| Cormorant Asset Management | Series B |
| 5AM Ventures | Series B, Seed, Series A |
| Logos Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2021
$80M round led by Kleiner Perkins and Cormorant Asset Management.
- Jan 3, 2018
$55.3M round led by Kleiner Perkins and Novartis.
Expansion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Expansion Therapeutics's valuation, stock price, and market status.